Brown Advisory’s Medifast MED Stock Holding History

Brown Advisory’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,727	Closed	-$2.27M	–	1109
2021 Q1	$2.27M	Sell	10,727 -10,000	-48%	-$2.39M	﹤0.01%	578
2020 Q4	$4.07M	Hold	20,727	–	–	0.01%	452
2020 Q3	$3.41M	Sell	20,727 -23,757	-53%	-$3.91M	0.01%	444
2020 Q2	$6.17M	Buy	44,484 +20,627	+86%	+$1.89M	0.01%	369
2020 Q1	$1.49M	Buy	23,857 +82	+0.3%	+$7.46K	﹤0.01%	513
2019 Q4	$2.6M	Hold	23,775	–	–	0.01%	488
2019 Q3	$2.46M	Hold	23,775	–	–	0.01%	489
2019 Q2	$3.05M	Sell	23,775 -522	-2%	-$72.5K	0.01%	469
2019 Q1	$3.1M	Buy	24,297 +729	+3%	+$92.5K	0.01%	538
2018 Q4	$2.95M	Buy	23,568 +749	+3%	+$128K	0.01%	509
2018 Q3	$5.05M	Sell	22,819 -269	-1%	-$54.5K	0.01%	441
2018 Q2	$3.7M	Buy	23,088 +118	+0.5%	+$15.1K	0.01%	505
2018 Q1	$2.15M	Buy	22,970 +7,880	+52%	+$589K	0.01%	510
2017 Q4	$1.05M	Hold	15,090	–	–	﹤0.01%	661
2017 Q3	$896K	Hold	15,090	–	–	﹤0.01%	687
2017 Q2	$626K	Hold	15,090	–	–	﹤0.01%	791
2017 Q1	$670K	Buy	15,090 +4,975	+49%	+$214K	﹤0.01%	729
2016 Q4	$421K	Hold	10,115	–	–	﹤0.01%	835
2016 Q3	$382K	Hold	10,115	–	–	﹤0.01%	828
2016 Q2	$337K	Buy	+10,115	New	+$326K	﹤0.01%	832

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Brown Advisory's MED Position: Q2 2021 in Review

Brown Advisory sold out of Medifast (MED) in Q2 2021, closing a stake of 10,727 shares — an estimated $2.27M sold.

Brown Advisory first reported a position in MED in Q2 2016 and held it in 20 quarters. The position peaked at $6.17M in Q2 2020. 301 funds tracked by Wall St. Rank hold MED as of Q2 2021.

Brown Advisory reported no remaining Medifast position as of Q2 2021 after selling out during the quarter.
Brown Advisory sold 10,727 Medifast shares in Q2 2021, an estimated $2.27M.
Brown Advisory first reported a position in Medifast in Q2 2016 and held it in 20 quarters.
Brown Advisory's Medifast position peaked at $6.17M in Q2 2020.
301 funds tracked by Wall St. Rank held Medifast as of Q2 2021.

Based on Brown Advisory's 13F filing for Q2 2021, filed 29 Jul 2021.